FDA Issues Heart Warning for Antibiotic

The FDA has issued a drug safety warning about the antibiotic Biaxin (clarithromycin) because it may potentially increase the risk of heart problems or death in people with heart disease years later. This new recommendation regarding the drug, which is used to treat a variety of infections, comes after the agency analyzed the results from a 10-year follow-up study.

The agency said that this study identified an unexpected increase in deaths among patients with coronary heart disease who received a 2-week course of clarithromycin that became apparent after patients had been followed for at least 1 year or longer.

The new findings have prompted the FDA to add a new warning about this increased risk of death in patients with heart disease to the drug’s label.

Alanna M.

Alanna M. is a graduate of Pace University.

Did you find this article helpful?

Notify of
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…